We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Novel Neurosurgical System Helps Place Brain Implants

By HospiMedica International staff writers
Posted on 26 Apr 2011
A new magnetic resonance imaging (MRI) device guides surgeons as they implant deep brain stimulation (DBS) electrodes, making the procedure more comfortable for the patient. More...


The SurgiVision (Memphis, TN, USA) ClearPoint system is a neurosurgical navigation system designed to enable a range of stereotactic procedures in the brain via direct visualization of targets using intraoperative MRI images. The system consists of a disposable, MRI-compatible head-mounted adjustable-trajectory frame; a multichannel imaging head coil with integrated head fixation frame; a workstation and an MRI compatible computer and monitor with navigational software; and lastly, a complete MRI compatible surgical kit. The system can be used in any 1.5T scanner, and is compatible with existing MRI suites.

Developed in conjunction with researchers at the University of California, San Francisco (UCSF; USA), the technique allows surgeons to more accurately place the electrodes, potentially cutting surgery time in half. In addition, since the preliminary recording and testing step, which is conventionally done using smaller electrodes is eliminated from the process, it can be done while the patient is asleep. The UCSF researchers initial test results of the device were collected in six mock surgeries on three cadaver brains, as well as on dozens of artificial targets made of water- and gelatin-filled plastic. The study results were presented at the annual scientific meeting of the American Association of Neurological Surgeons (AANS), held during April 2011 in Denver (CO, USA).

"It's an evolutionary step in the way these surgeries are done,” said lead researcher and study presenter neurosurgeon Paul Larson, MD. "The system provides the accuracy and reliability for us to do these operations safely and effectively.”

DBS is a surgical treatment involving the implantation of a medical device called a brain pacemaker, which sends electrical impulses to specific parts of the brain. DBS in select brain regions has provided remarkable therapeutic benefits for otherwise treatment-resistant movement and affective disorders such as chronic pain, Parkinson's disease, tremor, and dystonia. Despite its long history, the underlying principles and mechanisms of DBS are still not clear.

Related Links:
SurgiVision
University of California, San Francisco


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.